Review: The management of the elderly with hypertension

Sign In to gain access to subscriptions and/or personal tools.

This Article

	Free Full Text (Free PDF) Free
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to Saved Citations
	Download to citation manager
	Request Permissions
	Request Reprints
	Add to My Marked Citations

Citing Articles

	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Articles by Bulpitt, C. J
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Bulpitt, C. J


Social Bookmarking

	What's this?

Christopher J Bulpitt

Care of the Elderly Imperial College School of Medicine, Hammersmith Campus London UK, c.bulpitt@ ic.ac.uk

Key Words: hypertension • elderly • target blood pressure • antihypertensive drugs

References

Ramsay LE, Williams B., Johnston GD et al. British Hypertension Society guideline for hypertension management 1999: summary. BMJ 1999;319:630-5.[Free Full Text]

Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-83.[Web of Science][Medline] [Order article via Infotrieve]

Fletcher AE, Bradley IC, Broxton JS et al. Survival of hypertensive subjects identified on screening: results for sustained and unsustained diastolic hypertension.EurHeart 1992;13:1595-601.

Staessen JA, Fagard R.,Thijs L. et al., for the SYST-EUR trial investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Fagard RH, Staessen JA, Thijs L. et al., for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Response to Antihypertensive Therapy in Older Patients with Sustained and Nonsustained Systolic Hypertension. Circulation 2000; 102:1139-44.[Abstract/Free Full Text]

SHEP Co-operative Research Group. Prevention of Stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265: 3255-64.[Abstract/Free Full Text]

Amery A., Birkenhäger W., Brixko P. et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly. Lancet 1985;I:1349-54.

Hansson L., Zanchetti A., Carruthers SG et al., for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principle results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Kaplan N. J-curve not burned off by HOT study. Lancet 1998;351:1748-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Somes GW, Pahor M., Shorr RI, Cusham WC,Applegate WB The role of diastolic blood pressure when treating isolated systolic hypertension.Arch Intern Med 1999;159:2004-9.[Abstract/Free Full Text]

Fletcher AE, Bulpitt CJ How far should blood pressure be lowered? New Engl J Med 1992;326:251-54.[Web of Science][Medline] [Order article via Infotrieve]

Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291:97-104.[Abstract/Free Full Text]

MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992;304:405-12.[Abstract/Free Full Text]

Messerli FH, Grossman E., Goldbourt U. Are β-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998;279:1903-7.[Abstract/Free Full Text]

Psaty BM, Smith NL, Siscovick DS et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta analysis. JAMA 1997; 277:739-45.[Abstract/Free Full Text]

Hansson L., Lindholm LH, Ekbom T. et al., for the STOP-Hypertension-2 Study group. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity - the Swedish Trial in Old Patients with Hypertension - 2 study. Lancet 1999;354:1751-56.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Davis BR, Cutler JA, Gordon DJ et al. Rationale and design for the Antihypertensive and Lipid LoweringTreatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens 1996;9:342-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Lim PO, Donan PT, MacDonald TM Does the Dundee Step Test predict outcome in treated hypertension? A sub-study protocol for the ASCOT trial.Anglo-Scandinavian Cardiac Outcome Trial. J Hum Hypertens 2000;14:75-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Major cardiovascular events in hypertensive patients randomised to doxazosin vs chlorthalidone: the antihypertensve and lipid-lowering treatment to prevent heart attack trial (ALLHAT).ALLHAT Collaborative Research Group. JAMA 2000; 283:1967-75.[Abstract/Free Full Text]

Grimm RH Jr, Margolis KL, Papademetriou V. et al. Baseline characteristics of Participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2001;37:19-37.[Abstract/Free Full Text]

Curb JD, Pressel SL, Cutler JA et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276:1886-92.[Abstract/Free Full Text]

Tuomilehto J., Rastentyte D., Birkenhäger W. et al. Effect of calcium-channel blockade in older patients with diabetes and systolic hypertension. New Engl J Med 1999;340:677-84.[Abstract/Free Full Text]

Fletcher AE, Bulpitt CJ Epidemiological aspects of cardiovascular disease in the elderly. J Hypertens 1992;10:S51-S58.

Bulpitt CJ, Fletcher AE,Amery A. et al. The Hypertension in the Very ElderlyTrial (Hyvet): Rationale, methodology and comparison with previous trials. Drugs Aging 1994;5:171-83.[Web of Science][Medline] [Order article via Infotrieve]

Gueyffier F., Bulpitt CJ, Boissel JP et al., for the INDANA Group. Antihypertensive drugs in the very old people: a subgroup meta-analysis of randomised controlled trials. Lancet 1999; 353:793-96.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Bulpitt CJ, Fletcher A., Beckett N. et al. The Hypertension in the Very Elderly Trial (HYVET): Protocol for the main trial. Drugs Aging 2001; (in press).